Epitranscriptomic stabilization of chromatin reader ZMYND8 by the METTL14–YTHDF1 axis drives breast cancer progression
ZMYND8, a chromatin reader with dual histone and methylation recognition capacity, has been implicated in various cellular processes, yet the upstream regulatory mechanisms controlling ZMYND8 expression in breast cancer (BC) remain incompletely understood. Here, we demonstrate that ZMYND8 is markedly upregulated in BC tissues and selected cell lines. Functionally, genetic silencing of ZMYND8 inhibits cell proliferation, suppresses clonogenicity, induces apoptosis, and impairs migratory and invasive capabilities in BC cells. Mechanistically, we identify ZMYND8 mRNA as an m⁶A-modified transcript. Integrated analysis of TCGA-BRCA and experimental validation reveal that METTL14, an m⁶A methyltransferase, enhances ZMYND8 expression by promoting m⁶A modification and stabilizing its mRNA transcript. Moreover, the m⁶A reader YTHDF1 binds to methylated ZMYND8 mRNA in a METTL14-dependent manner and safeguards its stability. Collectively, our findings uncover a METTL14–YTHDF1–ZMYND8 regulatory axis that facilitates BC progression and highlight ZMYND8 as a potential epitranscriptomic effector in BC.
Authors
- Tao Yang (ORCID: https://orcid.org/0000-0001-6178-1021)
- Yan Huang (ORCID: https://orcid.org/0000-0002-3151-5555)
- Ruiti Tang
- Lei Xiao (ORCID: https://orcid.org/0000-0002-0428-1749)
- Jingya Yi
- Ping Liu
- Xiong Liu
Institutions
- Hunan Normal University (CN)
- Hunan Mawangdui Hospital (CN)
- Hunan Provincial People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s12672-026-06150-2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00